This is the fourth episode of our new "Program on JAK Inhibitors for Atopic Dermatitis" series, hosted by expert dermatologist Dr. Christopher Bunick, MD, PhD. This episode, "Setting the Stage: Effective Onboarding of your AD Patients onto JAK Inhibitor Therapy", featuring expert dermatologist Dr. Ruth Ann Vleugels, MD, MPH discusses the following topics:

• Identifying ideal candidates for oral JAK inhibitor therapy

• Steps to initiate therapy and onboard new patients

• How to manage side effects and maintain adherence to treatment

• Case examples and real-world data